Otsuka has been granted a patent for a compound designed for cancer treatment, detailed in formula (I). The patent includes pharmaceutical compositions, manufacturing processes, and medical applications related to these compounds. GlobalData’s report on Otsuka gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Otsuka, was a key innovation area identified from patents. Otsuka's grant share as of July 2024 was 50%. Grant share is based on the ratio of number of grants to total number of patents.
The granted patent US12071429B2 outlines a method for treating various types of cancer through the administration of specific compounds characterized by a defined chemical structure. The claims detail a range of substituents (R1, R2, R3, etc.) that can be incorporated into the compounds, allowing for significant structural diversity. Notably, the compounds may include halogens, alkyl groups, and various functional groups such as carboxylic acids and hydroxyls. The patent specifies that certain compounds, including those with chloro or nitrile substituents, are particularly emphasized for their therapeutic potential. Additionally, the claims encompass a variety of specific chemical entities, including tautomers, solvates, and pharmaceutically acceptable salts.
The patent further delineates the application of these compounds in treating specific cancers, including non-small cell lung cancer, various forms of lymphoma, leukemia, and other hematological malignancies. The claims also extend to the treatment of myeloproliferative disorders and specific tumors such as neuroblastoma and glioblastoma. This comprehensive approach highlights the versatility of the compounds in targeting a wide array of cancer types, potentially offering new avenues for therapeutic intervention in oncology.
To know more about GlobalData’s detailed insights on Otsuka, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
